News Merck buys life sciences firm Bio-Techne in $11.3bn deal Merck KGaA is poised to increase the size of its life sciences business with an $11.3 billion deal to acquire rival Bio-techne.
News England starts screening newborns for rare disease SMA All newborns in England will be screened for rare muscle-wasting disease, spinal muscular atrophy, from 2027, in a landmark move for patients.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
